Roundhill GLP-1 & Weight Loss ETF's Roundhill GLP-1 & Weight Loss ETF (OZEM) has disclosed 30 total holdings in their latest N-PORT filing with the SEC for the
portfolio date of 2024-06-30. The current portfolio value is calculated to be $33.00 Mil, only including common equities, preferred
equities, ETFs, options and warrants for equities. The turnover rate is 0%.
Roundhill GLP-1 & Weight Loss ETF (OZEM)'s
Total Assets is $34.29 Mil , Total Liabilities is $1.30 Mil , Net Assets is $32.99 Mil.
In Roundhill GLP-1 & Weight Loss ETF (OZEM)'s current portfolio as of 2024-06-30, the top 5 holdings are
Eli Lilly and Co (LLY), Novo Nordisk AS (NVO), Zealand Pharma AS (OCSE:ZEAL), Chugai Pharmaceutical Co Ltd (TSE:4519) and Amgen Inc (AMGN),
not including call and put options.
Roundhill GLP-1 & Weight Loss ETF (OZEM) did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the ETF's current and past N-PORT holdings for Roundhill GLP-1 & Weight Loss ETF (OZEM), as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the ETF's latest trades and stock picks for Roundhill GLP-1 & Weight Loss ETF (OZEM), which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Roundhill GLP-1 & Weight Loss ETF.